a comprehensive presentation on the subject of spinal dysraphism and spina bifida and its neurosurgical management as well as the management of its various other types
7. Aims
⢠Essential Embryology
⢠Introduction to Spinal Dysraphism
⢠Types of Spinal Dysraphism
⢠Management Strategies
⢠Tethered Cord Syndrome
⢠Management of TCS
8. Objectives
⢠At the end of this presentation the audience
will be able to;
â Know the essential spine embryology & its
aberrations
â Appreciate the types of developmental spinal
anomalies & spinal dysraphism
â Understand Neurosurgical management
strategies for spinal dysraphism
â Get an overview of the sequelae of spinal
dysraphism and tethered cord syndrome
13. Embryology contd.
⢠Neural crest becomes
peripheral nervous
system (PNS)
⢠Neural tube becomes
central nervous system
(CNS)
⢠Somites become spinal
vertebrae.
Somites
14.
15. Spinal Dysraphism
⢠Incomplete closure of the neural tube around
third and fourth week of embryonic development
⢠Combined malformations of the vertebral column
and spinal cord
⢠Lesions types;
â Spina bifida cystica: closed lesions but outside skin
â Spina bifida aperta: lesions communicating with the
outside
â Spina bifida occulta: concealed, no skin defect
⢠Recently classified as Open and Closed spinal
Dysraphism (OSD and CSD)
16. Aetiology
⢠Familial tendency (2.5% vs. 0.2% risk in
general population)1
⢠Nutritional factors; social class difference in
incidence1,2
⢠Folic acid use preconception and during
pregnancy1,2,3
⢠Teratogens e.g., valproate, phenytoin,
alcohol etc3,5,6
⢠Homeobox and pax3 embryonic genes3
17. Pathogenesis
⢠Occurs between days 20 to 28 of gestation7
⢠Failure to close of the neural folds at the caudal
end of neural tube
⢠Followed by failure of closure of the caudal
somites, resulting in a gap of the spine
⢠The various varieties of spinal dysraphism are a
result of the time and extent of failure of the
neural tube closure7
18. Pathogenesis (contd.)
⢠Open Spinal Dysraphism:
â Most common; 95% cases
â A ratio of 9:1 of OSD to CSD
â Vertebral defect with meningeal or spinal cord as the
wall of the extruding cyst
â Almost all OSD are with Chiari II malformation and
Hydrocephalus
â Worst form is Rachischisis; associated with anencephaly
â Diagnosed antenatal or at birth
â Neurologic dysfunction is due to;
⢠Primary defect in development of the nervous tissue
⢠Exposure to amniotic fluid
⢠Injury during birth
19. Pathogenesis (contd.)
⢠Closed Spinal Dysraphism:
â 5% of cases; occult;
â With or without a subcutaneous mass
â Intact skin covering
â No meningeal or spinal cord cystic lesion
â Most subcutaneous masses are lipomatous
â Usually identified during investigation of urologic,
orthopaedic or dermal and limb problems8
20.
21. Classification
⢠Spina bifida cystica and aperta ď¨ Open
Spinal Dysraphism (OSD)
⢠Spina bifida occulta ď¨ Closed Spinal
Dysraphism (CSD)
⢠CSD is further subdivided by the presence or
absence of a subcutaneous mass
⢠Most recent and comprehensive
classification in use was proposed by Tortori-
Donati et al in 2000 9,10
23. Classification11 (contd.)
2. Closed Spinal Dysraphism (5%)
With a
subcutaneous mass
Without a
subcutaneous mass
Cervical ď¨ Cervical myelocystocele Simple ď¨ Tight filum terminale
Cervical
myelomeningocele
Intradural lipoma
Cervical meningocele Posterior spina bifida
Lumbosacral ď¨ Lipomyelomeningocele Complex ď¨ Diastematomyelia /
Diplomyelia
Lipomyeloschisis Neurenteric cysts
Dermal sinus
Caudal regression
syndrome
Dorsal enteric fistula
24. Myelomeningocele (MMC)
⢠Most common spinal birth defect
⢠Bony defect through which the spinal cord and its
coverings protrude
⢠Prevalence in Pakistan unknown (estimated at 5-
15/1000 live births)
⢠Almost all associated with Chiari II malformation
and hydrocephalus (85 â 95%)
⢠Lumbosacral involvement is the commonest1,2,3,10,11
25. Myelomeningocele (contd.)
⢠Antenatal diagnosis possible at 14 to 20
weeks
⢠Ultrasound, serum AFP, amniocentesis for
acetylcholinestrase (accuracy about 90%)
⢠T2 weighted MRI useful in delineating the
neurological defects antenatally
⢠Delivery is usually by C-Section
⢠Surgical Correction of the sac (48-72 hours)
⢠Management of Hydrocephalus require
special attention
26.
27. Surgical Management
⢠To treat or not to treat?
â Improving the quality of life
â Effectiveness of early and aggressive intervention
⢠John Larborâs Experiment (1970s)
â Withhold extreme measures for those with severe
anomalies
⢠Medical ethics and individual rights
â The right to health and the right to life is for everyone
â Education of the parents regarding care of the infant
â Role of the treating physician
28. Surgical Management
⢠Careful clinical assessment
â Spina bifida neurological scale
⢠Pre-op counseling of the parents regarding
neurological recovery
⢠Surgery is for prevention of infection & correcting
CSF leak
⢠Abnormal bladder function persists in most cases
⢠Lower limbs difficult to assess
â Preservation of L3 ď¨ ability to stand
â Preservation L4-L5 ď¨ ability to ambulate
29. Surgical Management
⢠antibiotics if the surgery has to be delayed
⢠Nursing in prone position or laterally, keeping the
defect wet with soaked gauze
⢠Complete excision of zona epitheliosa and
closure of the dural sac and skin is the goal of the
surgery
⢠Failure to achieve the above, results in inclusion
cysts and tethered cord
⢠Closure of the normal skin is done along the long
axis of the defect
32. Post-op care
⢠Wound complications, shunt malfunction,
hydromyelia, tethered cord or worsening CM II are
the common complication
⢠Care of the patient with MMC is lifelong requiring
paediatric, urologic, physiotherapic, orthopedic,
neurologic and psychologic support
⢠Stridor, apnoea and bradycardia are signals of
poor prognosis and a result of advancing CM II
⢠Hydrocephalus is either treated simultaneously,
before closure of MMC or after clinical appearance
33. Post-op outcome
⢠Ten to 15% of children die in the first 6 years of
their lives despite aggressive treatment
⢠75 to 80% with normal IQ
⢠Survival:
â 92% survive to 1 year
â 78% to 17 years of age
â 46% to age > 40 years
⢠It is to be remembered that surgical treatment
aims at reducing disability & death and not the
neurological deficits that has already occurred
⢠Hydrocephalus and shunt complications tend to
affect intelligence
34.
35. Closed Spinal Dysraphism & Tethered
Cord Syndrome
⢠Some conditions leading to anatomical tethering
of the cord are;
â Lipomyelomeningcele
â Diastematomyelia and Diplomyelia
â Anterior sacral meningocele
â Myelocystocele
â Dural dermal sinus
36. ⢠Tethering of the cord may result in significant
disabilities and prolonged morbidities
⢠The leading problems are pain, motor
weakness, urologic issues, dermatologic
manifestations, orthopedic problems and
psychologic sequelae
⢠These problems occasionally present in
infancy while a majority is diagnosed in late
childhood to early adulthood
37. ⢠All conditions need surgical intervention to
release the cord
⢠The primary aim of neurosurgical intervention
is to stop further progression and help in
good physical and neuro-rehabilitation
⢠A multidisciplinary approach and high degree
of clinical vigilance is necessary for diagnosis
⢠Signs and symptoms are non-specific to any
particular tethering cause
41. Lipomyelomeningocele
⢠derives from the secondary remnant cells of
the notochordsâ caudal end
⢠mature adipose tissue fused to the dorsal
dura and protruding through the spinal defect
⢠Eventually causes tethering
⢠Two main types;
â adherent to the dorsal surface of the cord itself
â Adherent to the lower part of conus and filum
⢠Treatment is laminectomy and untethering of
the cord
47. Diastematomyelia / Diplomyelia
⢠Also called Split Cord Malformations
⢠Caused by duplication of the cord either by an
intervening bony spur or dural septum
⢠Causes cord tethering and neurological problems
⢠Incontinence, gait abnormalities, lower limbs pain
and sensory loss in feet
⢠Associated with midline dermal stigmata, i.e.,
faunâs tail (but not specific)
⢠May be associated with scoliosis
50. Diastematomyelia / Diplomyelia
⢠Two types;
â Split cord with an intervening bony spur
â without bony spur
⢠Female preponderance
⢠MRI is the confirming investigation
⢠Treatment is laminectomy, followed by excision of
the bony spur and repair of dura
⢠There is small risk of neurologic deterioration post-
operatively which should be communicated to the
patients / parents
51. Anterior Sacral Meningocele
⢠Evagination of meningeal sac anteriorly into the
pelvic cavity through a defect in the sacrum
⢠Rare cause of cord tethering
⢠Usually found accidentally on DRE or investigations
for pelvic pathology/ rarely during a laparotomy
⢠Any breach of the meningeal wall may increase the
risk of meningitis
52. Anterior Sacral Meningocele
⢠Pelvic ultrasound, CT myelography or MRI are
useful investigations
⢠Treatment is surgical reduction of the meningeal
sac and closure of the defect some times with a
fascial patch
⢠A posterior sacral laminectomy is the preferred
approach
⢠Division of filum terminale is essential step for
untethering
54. Congenital Dermal Sinus
⢠A tubular connection between the skin surface
where the channel may end subcutaneously,
interspinous area, inside the spinal canal,
intradurally or intramedullary cystic extension
⢠This type of sinus may easily be mistaken with a
pilonidal sinus
⢠Differentiation is done by the dimple created by the
tethered overlying skin which is not the case in
pilonidal sinus
55. Congenital Dermal Sinus
⢠Treatment is by complete dissection of the sinus
tract and its excision in toto followed by water tight
closure of the dura and releasing the tethering
elements
⢠Extensive laminectomy is required in some cases
⢠Filum terminale is usually divided in the wake of
untethering of the cord
58. Surgical Management of TCS
⢠Tethered cord syndrome needs surgical correction
⢠The neurologic deterioration is improved in majority
of cases postoperatively
⢠A small risk of neurological deterioration still persist
even in experienced hands
⢠Almost all types of tethering lesions require removal
of the tethering elements and release of the spinal
cord
⢠All operated cases of MMC do have cord tethering,
but needs careful assessment before being labelled
as TCS
59.
60. Recent Advancements
⢠Foetal MMC repair is an advancing development
but no definitive data exists
⢠Results are favourable in decreasing neurologic
deficits and reducing the occurrence of CM II and
hydrocephalus
⢠No final consensus or guidelines; still experimental
⢠Issues of medical ethics; issue of two individuals
61. Pearls
⢠periconceptional folate results in a 72%
relative risk reduction in the recurrence of
spina bifida in subsequent children
⢠periconceptional folic acid intake results in a
42% relative risk reduction in the incidence
of first occurrence of spina bifida
⢠In patients with lumbosacral dimples, US
exam is more cost effective than MRI in
screening for occult spinal dysraphism
⢠the anomaly could not be eradicated due to
its multifactorial nature
62. References
1. Group MRCVRS. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet.
1991;338(8760):131-137.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J
Med. 1992;327(26):1832-1835.
3. Cochrane D, Wilson R, Steinbok P, et al. Prenatal spinal evaluation and functional outcome of patients born with myelomeningocele:
information for improved prenatal counselling and outcome prediction. Fetal Diagn Ther. 1996;11(3):159-168.
4. Luthy D, Wardinsky T, Shurtleff D. Cesarean section before the onset of labor and subsequent motor function in infants with
myelomeningocele diagnosed antenatally. N Engl J Med. 1991;324(10):662-666.
5. Rintoul N, Sutton L, Hubbard A, et al. A new look at myelomeningoceles: functional level, vertebral level, shunting, and the
implications for fetal intervention. Pediatrics. 2002;109(3):409-413.
6. Johnson M, Sutton L, Rintoul N, et al. Fetal myelomeningocele repair: short term clinical outcomes. Am J Obstet
Gynecol.2003;189(2):482-487.
7. Mazzola C, Albright A, Sutton L, et al. Dermoid inclusion cysts and early spinal cord tethering after fetal surgery for
myelomeningocele. N Engl J Med. 2002;347(4):256-259.
8. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med.
2011;364:993-1004.
9. Pang D, Dias M, Ahab-Barmada M. Split cord malformation: Part I: a unified theory of embryogenesis for double cord malformations.
Neurosurgery. 1992;31(3):451-480.
10. Gibson P, Britton J, Hall D, Hill C. Lumbosacral skin markers and identification of occult spinal dysraphism in neonates. Acta Paediatr.
1995;84(2):208-209.
11. Tortori-Donati P, Rossi A, Cama A. Spinal dysraphism: a review of neuroradiological features with embryological correlations and
proposal for a new classification. Neuroradiology. 2000 Jul;42(7):471-91.
12. James HE, Walsh JW. Spinal dysraphism. Curr Probl Pediatr. 1981;11(8):6-25.
13. Warder DE. Tethered cord syndrome and occult spinal dysraphism. Neurosurg Focus. 2001;10(1):e1.
14. Bulsara K, Zomorodi A, Enterline D, George T. The value of magnetic resonance imaging in the evaluation of fatty filum terminale.
Neurosurgery. 2004;54:375-379.
15. Kanev P, Bierbrauer K. Reflections on the natural history of lipomyelomeningocele. J Neurosurg. 1995;22(3):137-140.
16. Ăzek M, Cinalli G, Maixner W. J. The spina bifida, management and outcome. 1° ed. Springer-Verlag Italia 2008.
17. Oi S, Matsumoto S (1992) A proposed grading and scoring system for spina bifida : Spina bifida neuro-logical scale. Childs Nerv Syst
8:337-342